Treating COVID-19 patients with zinc in addition to hydroxychloroquine and azithromycin led to a higher rate of discharge from hospitals and a lower likelihood of dying, according to a new study.
Researchers at New York University’s School of Medicine reviewed records from roughly 900 patients with COVID-19, the disease caused by the CCP (Chinese Communist Party) virus.
